## Abstract ## BACKGROUND: It is unclear whether it is appropriate to transfer the followβup care of breast cancer (BrCa) survivors from cancer specialists to primary care physicians (PCPs). This contemporary study compared physician specialty and documented the longβterm surveillance of survivors
β¦ LIBER β¦
Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer : Cancer and Leukemia Group B 79804
β Scribed by Mira L. Katz; Kathleen A. Donohue; Catherine M. Alfano; Jeannette M. Day; James E. Herndon II; Electra D. Paskett
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 143 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
American Society of Clinical Oncology-re
β
Kerry Hollowell; Courtney L. Olmsted; Anne S. Richardson; H. Keith Pittman; Lisa
π
Article
π
2010
π
John Wiley and Sons
π
English
β 352 KB
π 1 views
Associations between lifestyle factors a
β
Catherine E. Mosher; Richard Sloane; Miriam C. Morey; Denise Clutter Snyder; Har
π
Article
π
2009
π
John Wiley and Sons
π
English
β 153 KB
π 2 views
Health-related quality of life in long-t
β
Electra Paskett; James Herndon II; Kathleen Donohue; Michelle Naughton; Stephen
π
Article
π
2009
π
John Wiley and Sons
π
English
β 260 KB
π 1 views
Long-term follow-up of cancer and leukem
β
Charles A. Schiffer; Richard Dodge; Richard A. Larson
π
Article
π
1997
π
John Wiley and Sons
π
English
β 127 KB
π 2 views
## METHODS. Updated data were obtained for 9 trials initiated by the CALGB between for the Cancer and Leukemia 1974 and 1992.
Quality of life among patients with Stag
β
Jeffrey Peppercorn; James Herndon II; Alice B. Kornblith; William Peters; Tim Ah
π
Article
π
2005
π
John Wiley and Sons
π
English
β 176 KB
π 1 views
## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either highβdose chemotherapy with autologous stem cell support (HDC) o